In Law360, Attorneys Analyze Growth Factors Driving Life Sciences Transactions and Collaborations
In a Law360 article, life sciences and IP transactions partners Amanda Austin and Abigail Gregor and associate Amanda White examined factors driving growth in life sciences transactions and collaborations.
The authors explain that despite economic challenges, they anticipate continued focus on deal activity in artificial intelligence, digital health and gene therapy, and unique revenue arrangements such as royalty financings and regional licensing of biomedical products. This deal activity includes collaborations and licensing arrangements, along with creative financing structures, that allow for funding and development of novel programs while working to maximize the value of their existing programs and products.